RxDoctor Payments Data

Walter Graham, MD

Family Medicine · Burley, IDNPI 1821031758

Payments from drug & device makers

$2,675in general payments, 2019–2025

Across 167 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$385
  • Pfizer$311
  • Lilly USA, LLC$258
  • AstraZeneca$240
  • Novo Nordisk$231
  • Xeris Pharmaceuticals, Inc.$144
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$2,57796%
  • Education$984%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,675 in reported general payments places this provider in the 85th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$72,470
Medicare patients
301
Services billed
1,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban196$157,089
Humira(Cf) PenAdalimumab11$132,170
FarxigaDapagliflozin Propanediol124$81,107
TrulicityDulaglutide61$60,981
MounjaroTirzepatide60$59,859
OzempicSemaglutide51$58,721
JardianceEmpagliflozin42$28,080
MyrbetriqMirabegron36$18,150
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog35$13,500
Fluticasone-SalmeterolFluticasone Propion/Salmeterol109$8,428
EntrestoSacubitril/Valsartan12$7,302
Tresiba Flextouch U-100Insulin Degludec13$6,222
Tresiba Flextouch U-200Insulin Degludec15$6,121
Lantus SolostarInsulin Glargine,hum.Rec.Anlog70$5,706
BelsomraSuvorexant13$5,513

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$311$157,089196 claims
Lilly USA, LLCTrulicity, Mounjaro$258$120,841121 claims
AstraZenecaFarxiga$240$81,107124 claims
Novo NordiskOzempic$231$58,72151 claims
Astellas Pharma US IncMyrbetriq$80$18,15036 claims
NovartisEntresto$23$7,30212 claims
MerckBelsomra$53$5,51313 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$71$5,16011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 803 family medicine providers in Idaho.

Other family medicine in Burley

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →